EROAD Limited — Director's Dealing 2021

Dec 7, 2021

==> picture [67 x 19] intentionally omitted <==

Initial Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EROAD Limited
Date this disclosure made:		6-Dec-21
Date on which issuer listed or appointment made:		1-Dec-21
Director or senior manager giving disclosure
Full name:		Selwyn Lyle Pellett
Name of listed issuer:		EROAD Limited
Name of related bodycorporate(if applicable):		Not applicable
Position held in listed issuer:		Executive director
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product:		Ordinary shares in EROAD Limited (ERD)
Number held in class:		1,835,797		9
Nature of relevant interest:		Registered holder and beneficial owner	Registered holder and beneficial owner
		Selwyn Pellett & Tracey Herman as
Current registered holder:		trustees of the Selwyn Pellett Family Trust.Selwyn Pellett is also a beneficary of the	Selwyn Pellett
		trust.

Summary of specified derivatives relevant interest (if applicable) Type of derivative: Class of underlying financial products: Details of derivative The notional value of the derivative (if any) or the notional amount of underlying products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price specified in the terms of the derivative(if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products:

For that derivative,-

Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: Certification

Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature ofperson authorised to sign on behalf of director or officer:
Date of signature:			6/12/2021
Name and title of authorised person:		Mark Heine, General Counsel